Effect of antidiabetics on the risk of hepatocellular carcinoma in patients with diabetes and metabolic dysfunction-associated steatotic liver disease

被引：0
|
作者：
Lee, Han Ah [1 ]
Kim, Hwi Young [1 ]
Seo, Yeon Seok [2 ]
Ahn, Sang Hoon [3 ]
Kim, Seung Up [3 ]
机构：
[1] Ewha Womans Univ Coll Med, Seoul, South Korea
[2] Korea Univ Coll Med, Seoul, South Korea
[3] Yonsei Univ Coll Med, Seoul, South Korea
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-246
引用
收藏
页码：S481 / S481
页数：1
相关论文
共 50 条
  • [21] Diabetes and metabolic dysfunction-associated steatotic liver disease, CVD: a continuum
    Chawla, Rajeev
    Kumar, Anshul
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2024, 44 (03) : 417 - 418
  • [22] Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk factor
    Platek, Anna E.
    Szymanska, Anna
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 9 (03) : 187 - 192
  • [23] Prevalence and Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease
    Plaza-Aulestia, Nahia
    Ibarguengoitia-Barrena, Oihane
    Sampedro-Andrada, Blanca
    Juan-Lopez, Cristina San
    Morillo-Montanes, Victoria
    Urionaguena, Irati
    Calvo, Itziar
    Seisdedos, David Montero
    Vega-Alvarez, Lucia
    Llorente, Jose Francisco Garcia
    Revenga, Nuria Vegas
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4669 - 4671
  • [24] Genetic Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease
    Pei, Yiying
    Goh, George Boon-Bee
    GUT AND LIVER, 2025, 19 (01) : 8 - 18
  • [25] GASTROINTESTINAL MALIGNANCY RISK IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
    Nwankwo, Chizoba N.
    Eun, Yong
    Nwankwo, Obinna T.
    Osman, Mohamed K.
    Culpepper-Morgan, Joan A.
    GASTROENTEROLOGY, 2024, 166 (05) : S1474 - S1474
  • [26] Identification of Risk Factors Associated with Metabolic Dysfunction-Associated Steatotic Liver Disease in Psoriatic Patients
    Kucuk, Kirley
    Moreno, Christophe
    Nijmi, Hassane
    Daoud, Mathieu
    Mintoff, Dillon
    Willaert, Fabienne
    Benhadou, Farida
    DERMATOLOGY, 2025, 241 (01)
  • [27] LIVER STIFFNESS MEASUREMENT AND HEPATOCELLULAR CARCINOMA RISK IN METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE
    John, Binu
    Deng, Yangyang
    Singal, Amit
    Dahman, Bassam
    HEPATOLOGY, 2024, 80 : S768 - S769
  • [28] Metabolic dysfunction-associated steatotic liver disease increases hepatocellular carcinoma risk in chronic hepatitis B patients: a retrospective cohort study
    Lin, Ming
    Gao, Bowen
    Peng, Mengnan
    Chen, Xuefang
    Xiao, Huanming
    Shi, Meijie
    Zhang, Xiujuan
    Zeng, Folai
    Chi, Xiaoling
    FRONTIERS IN PHYSIOLOGY, 2024, 15
  • [29] An updated overview on hepatocellular carcinoma in patients with Metabolic dysfunction-Associated Steatotic Liver Disease: Trends, pathophysiology and risk-based surveillance
    Armandi, Angelo
    Rosso, Chiara
    Caviglia, Gian Paolo
    Bugianesi, Elisabetta
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2025, 162
  • [30] MASKED HYPERTENSION IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE - AN UNDERESTIMATED RISK?
    Martin, Anna
    Lang, Sonja
    Demir, Muenevver
    Goeser, Tobias
    Steffen, Hans-Michael
    Kasper, Philipp
    JOURNAL OF HYPERTENSION, 2024, 42
12345